Filippiinit - englanti - FDA (Food And Drug Administration)

merck sharp & dohme (i.a.) corporation - pneumococcal polysaccharide vaccine, polyvalent - solution for injection (i.m./ s.c.) - each dose (0.5 ml) contains 25 mcg of each polysaccharide type (types 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f, 33f) dissolved in isotonic saline solution containing 0.25% phenol as a preservative.

Filippiinit - englanti - FDA (Food And Drug Administration)

faberco life sciences inc.; distributor: faberco life sciences inc. - pneumococcal polysaccharide conjugate vaccine (adsorbed) (10-valent) - suspension for injection (im) - each dose (0.5 ml) contains: serotypes 1,5,9v, 14, 19a, 19f, 23f, 7f, 6a 2 mcg each serotype 6b 4 mcg conjugated to crm197 carrier protein aluminum (as aluminum phosphate) 0.125 mg

Filippiinit - englanti - FDA (Food And Drug Administration)

faberco life sciences inc.; distributor: faberco life sciences inc. - pneumococcal polysaccharide conjugate vaccine. (adsorbed) (10-valent) - suspension for injection (im) - each dose (0.5 ml) contains: serotypes 1, 5, 9v, 14, 19a, 19f, 23f, 7f, 6a 2 mcg each serotype 6b 4 mcg conjugated to crm197 carrier protein aluminum (as aluminum phosphate) 0.125 mg thiomersal 0.005%

Filippiinit - englanti - FDA (Food And Drug Administration)

n/a; importer: merck sharp & dohme (i.a.) llc; distributor: merck sharp & dohme (i.a.) llc - pneumococcal polysaccharide conjugate vaccine, 15 valent (adsorbed) - suspension for injection (im) - formulation: each dose (0.5 ml) contains: streptococcus pneumoniae polysaccharide serotypes 1, 3, 4, 5, 6a, 7f, 9v, 14, 18c, 19a, 197, 22f, 23f, 33f- 2 ug streptococcus pneumoniae polysaccharide serotype 6b-4 ug crm197 -30ug

Jordania - englanti - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية سليمان طنوس وأولاده - suleiman tannous & sons co. ltd - pneumococcal polysaccharide serotypes (11,2 , 41,2 ,51,2 ,6b1,2 ,7f1,2 ,9v1,2 ,141,2 ,18c1,3 ,19f1,4,23f1,2 ) - - - - -

Kanada - englanti - Health Canada

sanofi pasteur limited - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 8; pneumococcal polysaccharide serotype 9n; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 10a; pneumococcal polysaccharide serotype 11a; pneumococcal polysaccharide serotype 12f; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 15b; pneumococcal polysaccharide serotype 17f; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 20; pneumococcal polysaccharide serotype 22f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 33f; pneumococcal polysaccharide serotype 2; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f - liquid - 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg; 25mcg - pneumococcal polysaccharide serotype 1 25mcg; pneumococcal polysaccharide serotype 8 25mcg; pneumococcal polysaccharide serotype 9n 25mcg; pneumococcal polysaccharide serotype 9v 25mcg; pneumococcal polysaccharide serotype 10a 25mcg; pneumococcal polysaccharide serotype 11a 25mcg; pneumococcal polysaccharide serotype 12f 25mcg; pneumococcal polysaccharide serotype 14 25mcg; pneumococcal polysaccharide serotype 15b 25mcg; pneumococcal polysaccharide serotype 17f 25mcg; pneumococcal polysaccharide serotype 18c 25mcg; pneumococcal polysaccharide serotype 19a 25mcg; pneumococcal polysaccharide serotype 19f 25mcg; pneumococcal polysaccharide serotype 20 25mcg; pneumococcal polysaccharide serotype 22f 25mcg; pneumococcal polysaccharide serotype 23f 25mcg; pneumococcal polysaccharide serotype 33f 25mcg; pneumococcal polysaccharide serotype 2 25mcg; pneumococcal polysaccharide serotype 3 25mcg; pneumococcal polysaccharide serotype 4 25mcg; pneumococcal polysaccharide serotype 5 25mcg; pneumococcal polysaccharide serotype 6b 25mcg; pneumococcal polysaccharide serotype 7f 25mcg - vaccines

Kanada - englanti - Health Canada

pfizer canada ulc - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 8; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 10a; pneumococcal polysaccharide serotype 11a; pneumococcal polysaccharide serotype 12f; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 15b; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 22f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 33f; corynebacterium diphtheriae crm-197 protein - suspension - 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 4.4mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 51mcg - pneumococcal polysaccharide serotype 1 2.2mcg; pneumococcal polysaccharide serotype 3 2.2mcg; pneumococcal polysaccharide serotype 4 2.2mcg; pneumococcal polysaccharide serotype 5 2.2mcg; pneumococcal polysaccharide serotype 6a 2.2mcg; pneumococcal polysaccharide serotype 6b 4.4mcg; pneumococcal polysaccharide serotype 7f 2.2mcg; pneumococcal polysaccharide serotype 8 2.2mcg; pneumococcal polysaccharide serotype 9v 2.2mcg; pneumococcal polysaccharide serotype 10a 2.2mcg; pneumococcal polysaccharide serotype 11a 2.2mcg; pneumococcal polysaccharide serotype 12f 2.2mcg; pneumococcal polysaccharide serotype 14 2.2mcg; pneumococcal polysaccharide serotype 15b 2.2mcg; pneumococcal polysaccharide serotype 18c 2.2mcg; pneumococcal polysaccharide serotype 19a 2.2mcg; pneumococcal polysaccharide serotype 19f 2.2mcg; pneumococcal polysaccharide serotype 22f 2.2mcg; pneumococcal polysaccharide serotype 23f 2.2mcg; pneumococcal polysaccharide serotype 33f 2.2mcg; corynebacterium diphtheriae crm-197 protein 51mcg

Kanada - englanti - Health Canada

merck canada inc - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 22f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 33f; corynebacterium diphtheriae crm-197 protein - suspension - 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 4mcg; 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 2mcg; 30mcg - pneumococcal polysaccharide serotype 1 2mcg; pneumococcal polysaccharide serotype 3 2mcg; pneumococcal polysaccharide serotype 4 2mcg; pneumococcal polysaccharide serotype 5 2mcg; pneumococcal polysaccharide serotype 6a 2mcg; pneumococcal polysaccharide serotype 6b 4mcg; pneumococcal polysaccharide serotype 7f 2mcg; pneumococcal polysaccharide serotype 9v 2mcg; pneumococcal polysaccharide serotype 14 2mcg; pneumococcal polysaccharide serotype 18c 2mcg; pneumococcal polysaccharide serotype 19a 2mcg; pneumococcal polysaccharide serotype 19f 2mcg; pneumococcal polysaccharide serotype 22f 2mcg; pneumococcal polysaccharide serotype 23f 2mcg; pneumococcal polysaccharide serotype 33f 2mcg; corynebacterium diphtheriae crm-197 protein 30mcg - vaccines

Kanada - englanti - Health Canada

pfizer canada ulc - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 23f; corynebacterium diphtheriae crm-197 protein - suspension - 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 4.4mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 34mcg - pneumococcal polysaccharide serotype 1 2.2mcg; pneumococcal polysaccharide serotype 3 2.2mcg; pneumococcal polysaccharide serotype 4 2.2mcg; pneumococcal polysaccharide serotype 5 2.2mcg; pneumococcal polysaccharide serotype 6a 2.2mcg; pneumococcal polysaccharide serotype 6b 4.4mcg; pneumococcal polysaccharide serotype 7f 2.2mcg; pneumococcal polysaccharide serotype 9v 2.2mcg; pneumococcal polysaccharide serotype 14 2.2mcg; pneumococcal polysaccharide serotype 18c 2.2mcg; pneumococcal polysaccharide serotype 19a 2.2mcg; pneumococcal polysaccharide serotype 19f 2.2mcg; pneumococcal polysaccharide serotype 23f 2.2mcg; corynebacterium diphtheriae crm-197 protein 34mcg - vaccines

Yhdysvallat - englanti - NLM (National Library of Medicine)

wyeth pharmaceutical division of wyeth holdings llc - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 54ec0se5pz) (streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:54ec0se5pz), streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 2vf3v7175u) (streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:2vf3v7175u), streptococcus pneumoniae type - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2.2 ug in 0.5 ml - in children 6 weeks through 5 years of age (prior to the 6th birthday), prevnar 13® is indicated for: in children 6 years through 17 years of age (prior to the 18th birthday), prevnar 13 is indicated for: risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. available data on prevnar 13 administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. a developmental toxicity study has been performed in female rabbits administered prevnar 13 prior to mating and during gestation. each dose was approximately 20 times the human dose. this study revealed no evidence of harm to the fetus due to prevnar 13 (see 8.1 data). data animal in a developmental toxicity study, female rabbits were administered prevnar 13 by intramuscular injection twice prior to mating (17 days an